Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
BridgeBio Pharma Inc
NASDAQ:BBIO
BridgeBio Pharma Inc
NASDAQ:BBIO
Price:
74.09
USD
4.75%
Market Closed
Market Cap:
$14.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
BridgeBio Pharma Inc
NASDAQ:BBIO
|
US |
|
A
|
AK Alrosa PAO
MOEX:ALRS
|
RU |
|
Acanthe Developpement SE
F:ADX
|
FR |
|
M
|
McDonald's Holdings Company Japan Ltd
XMUN:MJ8
|
JP |
|
Industrias Penoles SAB de CV
OTC:IPOAF
|
MX |
Wall St Price Targets
BBIO Price Forecast
Based on 23 analysts
Based on 23 analysts
+49% Upside
from
$74.09
today
BridgeBio Pharma Inc (BBIO)’s 12-month stock price forecast through October 2027 has a consensus target of $110.67, implying 49% upside. The forecast is based on price targets from 23 Wall Street analysts.
BBIO Analyst Rating
Based on 23 analysts
Based on 23 analysts
Analysts rate BBIO Strong buy, with 21 of 23 recommending Buy or Strong buy.
BridgeBio Pharma Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BBIO's stock price target?
Price Target
110.67
USD
110.67
USD
According to Wall Street analysts, the average 1-year price target for BBIO is 110.67 USD with a low forecast of 80.8 USD and a high forecast of 163.8 USD.
What is the Revenue forecast for BridgeBio Pharma Inc?
Projected CAGR
37%
37%
The compound annual growth rate for Revenue over the next 8 years is 37%.
What is the Gross Profit forecast for BridgeBio Pharma Inc?
Projected CAGR
36%
36%
The compound annual growth rate for Gross Profit over the next 8 years is 36%.